| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 167.869 | 82 |
| GSM780708 | Untreated after 4 days (C2_1) | 152.418 | 81 |
| GSM780709 | Untreated after 4 days (C3_1) | 119.075 | 78 |
| GSM780719 | Untreated after 4 days (C1_2) | 156.637 | 81 |
| GSM780720 | Untreated after 4 days (C2_2) | 165.084 | 82 |
| GSM780721 | Untreated after 4 days (C3_2) | 111.821 | 77 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 115.91 | 77 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 136.627 | 79 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 161.309 | 81 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 120.146 | 78 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 168.271 | 82 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 157.141 | 81 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 140.976 | 80 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 129.688 | 79 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 135.005 | 79 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 151.359 | 81 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 134.777 | 79 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 147.718 | 80 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 191.805 | 83 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 146.301 | 80 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 153.302 | 81 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 197.507 | 83 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 160.644 | 81 |